267. Deputy Marc MacSharry asked the Minister for Health when the drugs committee will conclude its deliberations (details supplied); when the drugs committee recommendations will be considered by the HSE board; when the Cabinet will consider the HSE recommendations on the provision of Orkambi in terms of sanction of the necessary resources to facilitate its provision to patients; and if he will make a statement on the matter. [4785/17]

Summary

267. Deputy Marc MacSharry asked the Minister for Health when the drugs committee will conclude its deliberations (details supplied); when the drugs committee recommendations will be considered by the HSE board; when the Cabinet will consider the HSE recommendations on the provision of Orkambi in terms of sanction of the necessary resources to facilitate its provision to patients; and if he will make a statement on the matter. [4785/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 1 February 2017

   Medicinal Products Availability

   267. Deputy Marc MacSharry asked the Minister for Health when the drugs committee will conclude its deliberations (details supplied); when the drugs committee recommendations will be considered by the HSE board; when the Cabinet will consider the HSE recommendations on the provision of Orkambi in terms of sanction of the necessary resources to facilitate its provision to patients; and if he will make a statement on the matter. [4785/17]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 1 February 2017

  ViewDownloadOpen at official source

Sponsors

• MacSharry, Marc. · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.